How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP)
Kévin Bigaut, Mikaël Cohen, Françoise Durand‐Dubief, Élisabeth Maillart, Evelyne Planque, Hélène Zéphir, Christine Lebrun‐Frénay, J. de Sèze
Topics & Concepts
OcrelizumabMedicineFingolimodMultiple sclerosisNatalizumabMitoxantroneAlemtuzumabCladribineRelapsing remittingSecond lineInternal medicinePediatricsPsychiatryFirst lineRituximabChemotherapyTransplantationLymphomaMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAmyotrophic Lateral Sclerosis Research